Nanovector Technology Solutions

About CARMA
NanoVectors

Bridging academic excellence and industrial innovation
through advanced nanotechnology

" The easiest way to succeed is to copy nature! "

CARMA NanoVectors Srl is a spin-off company of the University of Salerno, originating from the Department of Medicine, Surgery and Dentistry. Our mission is to bridge academic excellence and industrial innovation by developing next-generation nanovector technologies for biomedical, pharmaceutical, and precision medicine applications.
Our Nanosystem Platform unlike conventional lipid or polymer nanoparticles, which rely predominantly on synthetic materials, CARMA nanovectors bioinspired nanocarriers integrate functional lipid or membrane proteins derived from carefully selected biological sources into engineered nanocarriers.

This unique biomimetic architecture offers several key advantages:
Increased payload versatility
Enhanced biocompatibility
Natural cell-mimicking properties
Reduced non-specific interactions
Improved biological targeting

Our Team

A multidisciplinary team combining scientific, clinical and engineering expertise.

Prof. Giovanna Della Porta

CEO

Professor of medicinal chemistry at the University of Salerno, focused on advanced nanoformulations and translational nanomedicine.

VIEW PROFILE

Prof. Giovanna Della Porta

CEO

Professor at the University of Salerno and Head of the Translational Medicine and Nanomedicine Laboratories.

Her research focuses on advanced nanoformulations for gene and protein delivery and the development of 3D models for tissue engineering and regenerative medicine.

She leads a multidisciplinary team of researchers in biotechnology, biomedical engineering, and chemistry. She has coordinated national and European projects (Next Generation EU, Horizon 2020, PRIN-PNRR) worth over €1.5 million. She serves as an EIC Pathfinder evaluator, is active in international scientific networks, and is co-inventor of the university patent forming the technological foundation of the spin-off.

Prof. Antonietta Santoro

Board Member, Toxicology

Professor of human anatomy with expertise in translational toxicology and nanocarrier safety assessment.

VIEW PROFILE

Prof. Antonietta Santoro

Board Member, Toxicology

Professor of Human Anatomy at the University of Salerno and Co-Head of the Translational Medicine and Nanomedicine Laboratory.

She is an expert in experimental and translational toxicology, with extensive experience in preclinical models and innovative safety assessment approaches.

She has coordinated national and international projects in environmental toxicology and nanotechnology-based drug delivery and directs the SHIELD Observatory. Within the spin-off, she oversees preclinical validation, toxicological assessment of nanocarriers, and strategies supporting regulatory compliance and industrial translation.

Prof. Mario Vento

Board Member, AI Coordinator

Professor of AI and machine learning supporting predictive design and automated quality control.

VIEW PROFILE

Prof. Mario Vento

Board Member, AI Coordinator

Professor of Machine Learning and Artificial Intelligence at the University of Salerno.

He contributes expertise in predictive design through multi-parameter optimization models for precision nanomedicine. His work focuses on AI-driven platforms for immuno-nanomedicine, integrating biological and clinical data analysis.

He also leads the development of automated quality control systems based on computer vision and deep learning, improving manufacturing reliability, reproducibility, scalability, and data-driven decision-making for biomedical and pharmaceutical applications.

Dr. Erwin Pavel Lamparelli

Treasurer

Assistant Professor of medicinal chemistry specializing in biomimetic nanocarriers and regenerative medicine models.

VIEW PROFILE

Dr. Erwin Pavel Lamparelli

Treasurer

Assistant Professor at the University of Salerno and Coordinator of the Translational Medicine and Nanomedicine Laboratory.

His expertise includes biomimetic nanocarriers and 3D regenerative medicine models. He completed research training at Keele University (UK) and gained industrial experience at Novagenit. He is co-inventor of the patented lipid nanocarrier technology and has participated in Horizon 2020 and PNRR projects.

He contributes to the spin-off through the design, development, and validation of advanced drug delivery systems.

Prof. Ornella Piazza

Clinical Consultant

Professor of anesthesiology supporting the translation of innovative nanomedicine technologies into clinical practice.

VIEW PROFILE

Prof. Ornella Piazza

Clinical Consultant

Professor of Anesthesiology and Intensive Care at the University of Salerno and Director of the Department of Anesthesia and Intensive Care at the University Hospital of Salerno.

She supports the spin-off by identifying unmet clinical needs and facilitating the translation of innovative nanomedicine technologies into clinical practice.

Her expertise strengthens collaborations with healthcare institutions, regulatory authorities, and industrial partners, promoting the clinical adoption and dissemination of the company’s technologies.

Prof. Giorgio Iaconetta

Clinical Consultant

Professor of neurosurgery supporting nanomedicine translation, particularly for blood-brain barrier targeting.

VIEW PROFILE

Prof. Giorgio Iaconetta

Clinical Consultant

Professor of Neurosurgery at the University of Salerno and Director of the Neurosurgery Unit at the University Hospital of Salerno.

With experience as lead surgeon in more than 4,000 cranial and spinal procedures, his work focuses on brain tumor surgery and neuro-oncology.

He supports the spin-off by facilitating the clinical translation of innovative nanomedicine technologies, particularly for blood-brain barrier (BBB) targeting, while strengthening collaborations with hospitals, regulatory bodies, and industrial partners.

Prof. Antonio Mollo

Clinical Consultant

Professor of gynecology contributing to therapeutic applications, tissue selectivity and drug biodistribution.

VIEW PROFILE

Prof. Antonio Mollo

Clinical Consultant

Professor of Obstetrics and Gynecology at the University of Salerno and Director of the Obstetrics and Gynecology Unit at the University Hospital of Salerno.

His clinical expertise includes gynecologic oncology and degenerative diseases of the female reproductive system. Within the spin-off, he contributes to defining clinical needs and therapeutic applications, particularly regarding tissue selectivity and drug biodistribution.

He also supports collaborations with healthcare providers, regulatory agencies, and industrial stakeholders.

Eng. Federica Montella

Process Development

Chemical engineer focused on scalable nanovesicle manufacturing and formulation optimization.

VIEW PROFILE

Eng. Federica Montella

Process Development

Chemical Engineer and Research Fellow at the University of Salerno, specializing in the formulation of nanovesicles for immunotherapy using advanced microfluidic technologies.

She has contributed to PRIN-funded projects on sustainable materials and possesses expertise in HPLC, Dynamic Light Scattering (DLS), spectrophotometry, and supercritical fluid processing.

She supports the spin-off by developing scalable manufacturing processes, optimizing formulations, and implementing analytical methods for innovative nanomedicine production.

Eng. Francesco Pansera

Logistics

Biomedical engineer supporting logistics, workflow optimization and technology transfer.

VIEW PROFILE

Eng. Francesco Pansera

Biomedical Engineering & Logistics

Biomedical Engineer with expertise in medical devices, logistics, and healthcare technology management.

He contributes to the optimization of biomedical workflows, device integration, and operational planning, supporting efficient coordination between research laboratorie sand  industrial stakeholders.

Within the spin-off, he focuses on biomedical engineering solutions, logistics management, and the implementation of scalable processes that facilitate technology transfer, regulatory compliance, and the commercialization of innovative nanomedicine products.

Dr. Saveria Batti

Quality Control

Medical biotechnologist focused on cellular models, lipid nanocarriers and molecular characterization.

VIEW PROFILE

Dr. Saveria Batti

Medical Biotechnologist Quality Control

Medical Biotechnologist and Research Fellow at the University of Salerno. Her research focuses on advanced cellular models and lipid nanocarriers for protein delivery.

She has extensive experience in CRISPR/Cas9 genome editing, induced pluripotent stem cell (iPSC) technologies, cellular reprogramming, and molecular biology.

Author of several scientific publications and international conference presentations, she contributes to the spin-off through translational research, in vitro validation, and molecular characterization of innovative therapeutic platforms.

Eng. Vito Foresta

Industrial Scale-Up

Civil engineer supporting process optimization, technology transfer and industrial scale-up.

VIEW PROFILE

Eng. Vito Foresta

Industrial Scale-Up

Civil Engineer with expertise in laboratory management, data analysis, and mathematical modeling.

He has supported several national and international research projects by integrating engineering, computational, and statistical methodologies.

Within the spin-off, he contributes to process optimization, technology transfer, and industrial scale-up, promoting collaboration between academia and industry to accelerate the commercialization of advanced nanomedicine technologies.

Dr. Raffaella D'Auria

Quality Control Lab Manager

Biologist specialised on in vitro validation and biological characterization.

VIEW PROFILE

Dr. Raffaella D'Auria

Quality Control Lab Manager

Technical Officer at the University of Salerno and member of the Translational Medicine and Nanomedicine Laboratory.

She specializes in advanced cell culture models and flow cytometry for evaluating cytotoxicity, inflammatory responses, and regenerative processes. She has participated in multidisciplinary nanomedicine projects focused on innovative drug delivery systems.

Within the spin-off, she is responsible for in vitro validation, biological characterization, and quality control of nanocarrier formulations.

Eng. Clemente Celano

Industrialization

Chemical engineer supporting industrialization, manufacturing scale-up and technology transfer. 

VIEW PROFILE

Eng. Clemente Celano

Industrialization

Chemical Engineer and Production Director at a multinational company in the plastics and packaging sector.

He has held leadership roles in R&D and industrial operations, gaining expertise in lean manufacturing, CE certification, industrial safety, and process optimization.

Within the spin-off, he supports industrialization strategies, manufacturing scale-up, quality management, and technology transfer, facilitating collaborations with industrial partners and accelerating market deployment.